<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04897451</url>
  </required_header>
  <id_info>
    <org_study_id>CHD21-0028</org_study_id>
    <nct_id>NCT04897451</nct_id>
  </id_info>
  <brief_title>Quality of Life After Cervical Ripening</brief_title>
  <acronym>MATUCOL-QOL</acronym>
  <official_title>Quality of Life 3 Months After Cervical Ripening</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Departemental Vendee</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Departemental Vendee</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Women's experience of childbirth differs with type of labor, mode of delivery and parity.&#xD;
      Induction of labor (IOL) is associated with lower satisfaction of women than spontaneous&#xD;
      labor.&#xD;
&#xD;
      A Nigerian study of 252 women with induced labor, irrespective of parity and device used for&#xD;
      IOL and a French cohort study of 3042 women with IOL have been published. Theses latter&#xD;
      identified several determinants of maternal dissatisfaction.&#xD;
&#xD;
      However, no published study has reported the assessment of quality of life of women at long&#xD;
      term after cervical ripening according to the device required for cervical ripening.&#xD;
&#xD;
      The aim of this study is to characterize the quality of life of women after cervical ripening&#xD;
      according to parity and device required, and to assess possible factors associated with this&#xD;
      quality of life at long-term after delivery.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">May 2021</start_date>
  <completion_date type="Anticipated">May 2023</completion_date>
  <primary_completion_date type="Anticipated">May 2023</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>3 Months</target_duration>
  <primary_outcome>
    <measure>EQ-5D-5L Score</measure>
    <time_frame>3 months after delivery</time_frame>
    <description>5-level EQ-5 dimensions score. Quality of life score in 5 dimensions</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Delivery</condition>
  <arm_group>
    <arm_group_label>Women with cervical ripening in the context of artificial labor induction</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>questionnaire</intervention_name>
    <description>EQ5D-5L questionnaire self-reported 3 months after delivery</description>
    <arm_group_label>Women with cervical ripening in the context of artificial labor induction</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All Women who experienced at least one method of cervical ripening in our hospital.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        - Woman who experienced at least one method of cervical ripening in our hospital&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        - Patient's refusal&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Guillaume DUCARME</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHD Vendee</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Stéphanie MARTIN</last_name>
    <phone>+33251446483</phone>
    <email>stephanie.martin@chd-vendee.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHD Vendée</name>
      <address>
        <city>La Roche Sur Yon</city>
        <zip>85000</zip>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>stéphanie MARTIN</last_name>
      <phone>+33151446483</phone>
      <email>stephanie.martin@chd-vendee.fr</email>
    </contact>
    <investigator>
      <last_name>Guillaume DUCARME</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>May 18, 2021</study_first_submitted>
  <study_first_submitted_qc>May 18, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 21, 2021</study_first_posted>
  <last_update_submitted>May 18, 2021</last_update_submitted>
  <last_update_submitted_qc>May 18, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 21, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

